SCHEMBL25897470

SCHEMBL25897470

CCOC(=O)c1ccc(-n2cc(CC)nn2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.62
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ APP P05067 2/20 0.54
▸ HPGD P15428 3/20 0.52
▸ HTT P42858 2/20 0.52
▸ MAOA P21397 2/20 0.51
▸ MAOB P27338 1/20 0.51
▸ NOTUM Q6P988 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ HSP90AA1 P07900 1/20 0.50
▸ CACNA1B Q00975 1/20 0.50
▸ APBA1 Q02410 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ PSMD10 O75832 1/20 0.48
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ ESR1 P03372 1/20 0.47
▸ CA7 P43166 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16491147 0.82 MAOA (0.73) POLBL3MBTL1MAOAMAOBNOTUM
SCHEMBL23386979 0.81 POLB (0.53) POLBL3MBTL1APPHPGDHTT
SCHEMBL22532624 0.77 MAOA (0.61) POLBL3MBTL1APPHPGDMAOA
SCHEMBL20468184 0.77 NOTUM (0.72) POLBL3MBTL1NOTUMRXRAGRIN1
SCHEMBL22111817 0.76 MIF (0.69) L3MBTL1NOTUMCA12CA1CA2
SCHEMBL19126510 0.74 PSMD10 (0.55) POLBL3MBTL1APPMAOAMAOB
SCHEMBL29828653 0.74 P2RX7 (0.67) POLBL3MBTL1APPHPGDMAOA
SCHEMBL2041625 0.73 CA1 (0.57) HPGDALDH1A1CA12CA1CA2
SCHEMBL87450 0.73 CA1 (0.83) HPGDHTTMAOAALDH1A1HSP90AA1
SCHEMBL22015905 0.72 HPGD (0.65) HPGDHTTMAOAALDH1A1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233689-A1 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins UNIV YALE (US) 2023-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230233689-A1 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins ASGR1, LDLR, FCGR2A POLB 4149/4885L3MBTL1 1095/4885APP 1211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback